Greenwich LifeSciences, Inc. GLSI
16.81 USD +0.35 +2.13%
As of Nov 3, 12:07 PM ET
- YTD
- -19.99%
- 1 year
- +99.41%
- Open
- 16.70
- Prev close
- 16.46
- Mkt cap
- 245.98M
- Vol
- 19.01K
- Avg vol
- 127.91K
- EPS
- -1.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.70
- High
- 17.21
- Forward P/E
- -14.83
- Beta
- 3.32
- Short ratio
- 21.41
- Inst. own
- 8.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 13.57
- 200-d avg
- 14.65
- 1y target
- 38.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for GLSI has not been loaded yet. Try again in a moment.
Altman Z-Score
2.27 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -14.7×
P/S 0.0×
P/B 805×
P/FCF -28.7×
EV/EBITDA -14.4×
EV/Sales 0.0×
FCF Yield -3.5%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -5480.5%
ROIC -5505.9%
ROA -313.3%
Revenue 0.0%
Operating Income -10.3%
EPS (diluted) -18.2%
Free Cash Flow -36.4%
Current Ratio 1.1×
Quick Ratio 1.1×
Debt / Equity 0.0×
Net Debt / EBITDA 0.3×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31